NCT04075396 2025-04-29A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)Janssen Research & Development, LLCPhase 1/2 Completed29 enrolled 53 charts